Immediate Impact

1 from Science/Nature 49 standout
Sub-graph 1 of 24

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
1 intermediate paper

Works of Ryan Gillihan being referenced

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
2011

Author Peers

Author Last Decade Papers Cites
Ryan Gillihan 12 38 21 180 111 12 352
Tim Nichols 1 15 11 155 262 12 409
Cuihong Wei 3 36 7 147 116 16 358
Chia-Li Yu 6 11 46 97 109 10 324
Esther Mena Gonzalez 16 8 188 28 9 306
Irene Grimani 8 21 2 166 44 11 357
Alan Solomon 10 21 52 216 10 307
Franklin Mullinax 12 52 55 238 10 391
C. S. Killian 2 16 53 97 114 11 409
C.E. Newman 9 27 4 152 88 18 366
Kald Abdallah 3 18 10 216 51 13 378

All Works

Loading papers...

Rankless by CCL
2026